Get started
Soligenix, Inc.Soligenix, Inc.Soligenix, Inc.

Soligenix, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

SNGX chart


Full chart

SNGX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪8.81 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−7.80 USD
Net income (FY)
‪−6.14 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪2.51 M‬
Beta (1Y)
1.54

Employees


Employees (FY)
15
Change (1Y)
0
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−409.38 K‬ USD

About Soligenix, Inc.


Sector
Health Technology
CEO
Christopher J. Schaber
Headquarters
Princeton
Website
soligenix.com
Founded
1987
FIGI
BBG000FVMHG5
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses on the development of a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Public Health Solutions segment consists of active development programs for RiVax, a ricin toxin vaccine candidate, and SGX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease. The company was founded in 1987 and is headquartered Princeton, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

SNGX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SNGX is 3.36 USD — it has decreased by −0.57% in the past 24 hours. Watch Soligenix, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Soligenix, Inc. stocks are traded under the ticker SNGX.
SNGX stock has fallen by −4.88% compared to the previous week, the month change is a −7.63% fall, over the last year Soligenix, Inc. has showed a −49.37% decrease.
SNGX reached its all-time high on Jul 3, 1996 with the price of 1,800,000.00 USD, and its all-time low was 1.83 USD and was reached on Jul 8, 2024. View more price dynamics on SNGX chart.
See other stocks reaching their highest and lowest prices.
SNGX stock is 4.46% volatile and has beta coefficient of 1.54. Track Soligenix, Inc. stock price on the chart and check out the list of the most volatile stocks — is Soligenix, Inc. there?
Today Soligenix, Inc. has the market capitalization of ‪8.81 M‬, it has decreased by −4.62% over the last week.
Yes, you can track Soligenix, Inc. financials in yearly and quarterly reports right on TradingView.
Soligenix, Inc. is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
SNGX earnings for the last quarter are −0.78 USD per share, whereas the estimation was −1.39 USD resulting in a 43.88% surprise. The estimated earnings for the next quarter are −0.95 USD per share. See more details about Soligenix, Inc. earnings.
Soligenix, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of ‪200.00 K‬ USD. In the next quarter, revenue is expected to reach ‪200.00 K‬ USD.
SNGX net income for the last quarter is ‪−1.72 M‬ USD, while the quarter before that showed ‪−1.64 M‬ USD of net income which accounts for −4.55% change. Track more Soligenix, Inc. financial stats to get the full picture.
No, SNGX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 15.00 employees. See our rating of the largest employees — is Soligenix, Inc. on this list?
Like other stocks, SNGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Soligenix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Soligenix, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Soligenix, Inc. stock shows the sell signal. See more of Soligenix, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.